申请人:Advanced Proteome Therapeutics Inc.
公开号:US11400165B2
公开(公告)日:2022-08-02
The present disclosure provides methods for site-selectively crosslinking payloads to antibodies and other proteins. This can be accomplished using traceless affinity labels designed to label target proteins with bio-orthogonally reactive entities (ORE) using the compositions and methods described herein.
本公开提供了将有效载荷与抗体和其他蛋白质进行位点选择性交联的方法。这可以使用无踪亲和标签来实现,无踪亲和标签的目的是利用本文所述的组合物和方法,用生物正交反应实体(ORE)标记目标蛋白质。